Format: 1-hour Virtual Thought Leadership Session
Date & Time: 15th October 2025, 1:30–2:30 PM BST / 8:30–9:30 AM EST
Platform: Zoom
1:30 PM – Thought Leader Interview (20 mins)
Interview with: Dominic Rothwell, Deputy Director, Manchester Cancer Biomarker Centre, Cancer Research UK (CRUK), Cancer Research Horizons
2:00 PM – Panel Discussion (30 mins)
Panel Discussion Title: Advancing Biomarker-Driven Innovation- Collaborations & Partnerships
- Data sharing and standardisation
- Real-time tissue/cfDNA sampling and repositories
- Joint protocol design for biomarker-driven trials
- Public–private and multi-centre consortia
Discussion will include:
- How cfDNA and tumour biomarkers are enabling earlier, more accurate interventions
- What strong research–clinical–industry partnerships look like
- Where collaborations are currently delivering the most impact
Moderator: Dominic Rothwell, Deputy Director, Manchester Cancer Biomarker Centre, Cancer Research UK (CRUK), Cancer Research Horizons
Panellists:
Nathalie Dhomen, MCRC Commercialisation and Innovation Lead, Cancer Research UK Manchester Institute
James Hadfield, Senior Director (Epigenomics), Oncology Translational Medicine, AstraZeneca
To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.
Secure all the benefits and sign-up for Premium membership now
*If you’re already a Premium member your exclusive invite will be sent direct to your inbox